The company has expanded its services for solid-dose potent and cytotoxic products in response to robust market demand. A recently installed state-of-the-art dry granulation roller compactor provides flexibility and efficiency for potent drug product needs. The new compactor is housed in a dedicated manufacturing suite in the company’s multi-product potent facility in Sligo, Ireland. The new roller compactor offers precise process control, measuring all product quality relevant parameters online for a well controlled, documented manufacturing process. All parameters are calibrated and validated. The output of the new roller compactor is small, uniform particles for tablets or capsules, and more reliable results, minimizing output uncertainty. Operating for almost a decade, The company’s 110,000-square-foot Sligo facility has the capability of manufacturing a wide range of potent pharmaceuticals, from active pharmaceutical ingredients to finished goods.
AbbVie Inc., North Chicago, IL 60064. www.abbviecontractmfg.com or call 800-240-1043
INTERPHEX 2013 Booth No. 1304